NeuroVision was formed in 2010 and is headquartered in Sacramento, California. The company develops digital imaging and diagnostic solutions for Alzheimer's disease (AD).
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/30/16 | $5,000,000 | Series B |
Wildcat Capital Management | undisclosed |
